Philadelphia VA Medical Center PADRECC
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT01502995
The purpose of this study is to determine whether a laser light beam, attached to a rolling walker and projected onto the floor, reduces freezing episodes in patients with Parkinson's disease.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 3
Philadelphia, Pennsylvania, 19104, United States
Freezing of gait is a debilitating feature of Parkinson's disease. This study aims to determine whether a laser light beam, attached to a rolling walker and projected onto the floor, reduces freezing episodes. Patients will perform two trials of 3 timed walking tasks: once with the laser beam and once without. For each trial, the time to complete, number of steps, and number of freezing episodes will be recorded. Patients will be randomized to perform the first trial either with the light or without the light, to control for fatigue.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of a laser light on a rolling walker during episodes of freezing of gait.
Other names: U-Step Walking Stabilizer with laser light
Time frame: Two hours
Time in seconds for subject to complete the designated walking task.
Time frame: Two hours
Number of steps taken to complete the designated walking task.
Time frame: Two hours
Number of freezing episodes that occur during walking task.
Parkinson's Disease Research, Education, and Clinical Center, Philadelphia
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02302144
Basal Ganglia Diseases, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04653688
Basal Ganglia Diseases, Brain Diseases
Lille, France
View Trial DetailsNCT03843268
Basal Ganglia Diseases, Brain Diseases
Roma, Italy
View Trial DetailsNCT06073028
Basal Ganglia Diseases, Brain Diseases
Créteil, France
View Trial Details